PsyPress Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
PsyPress General Information
Description
Developer of a digital speech analytics platform designed to predict psychosis relapses. The company's platform utilizes everyday speech analytics to monitor patterns in tonality, pausing, and coherence against personal baselines, enabling care teams to receive automated alerts and provide proactive intervention up to two weeks before a relapse occurs.
Contact Information
Corporate Office
- Cambridge
- England, United Kingdom
Corporate Office
- Cambridge
- England, United Kingdom
PsyPress Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 18-Sep-2025 | Completed | Startup |
PsyPress Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Founders at the University of Cambridge | Accelerator/Incubator |
PsyPress FAQs
-
Where is PsyPress headquartered?
PsyPress is headquartered in Cambridge, United Kingdom.
-
What industry is PsyPress in?
PsyPress’s primary industry is Business/Productivity Software.
-
Is PsyPress a private or public company?
PsyPress is a Private company.
-
What is PsyPress’s current revenue?
The current revenue for PsyPress is .
-
Who are PsyPress’s investors?
Founders at the University of Cambridge has invested in PsyPress.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process